5441722026-01-012026-03-315441722026-03-315441722025-03-315441722025-04-012026-03-315441722026-01-012026-03-31in-capmkt:OtherExpenses1Member5441722025-04-012026-03-31in-capmkt:OtherExpenses1Member5441722026-03-31OtherNoncurrentFinancialAssetsDomain15441722026-03-31OtherNoncurrentAssetsDomain15441722026-03-31OtherNoncurrentAssetsDomain25441722026-03-31OtherCurrentFinancialAssetsDomain15441722026-03-31OtherCurrentAssetsDomain15441722026-03-31OtherNoncurrentFinancialLiabilitiesDomain15441722026-03-31OtherNoncurrentFinancialLiabilitiesDomain25441722026-03-31OtherCurrentFinancialLiabilitiesDomain15441722026-03-31OtherCurrentFinancialLiabilitiesDomain25441722026-03-31OtherCurrentLiabilitiesDomain15441722026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15441722025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15441722026-01-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15441722025-04-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15441722026-01-012026-03-31RelatedPartyTransactionDomain15441722025-12-31RelatedPartyTransactionDomain15441722026-03-31RelatedPartyTransactionDomain15441722026-01-012026-03-31RelatedPartyTransactionDomain25441722025-12-31RelatedPartyTransactionDomain25441722026-03-31RelatedPartyTransactionDomain25441722026-01-012026-03-31RelatedPartyTransactionDomain35441722025-12-31RelatedPartyTransactionDomain35441722026-03-31RelatedPartyTransactionDomain35441722026-01-012026-03-31RelatedPartyTransactionDomain45441722025-12-31RelatedPartyTransactionDomain45441722026-03-31RelatedPartyTransactionDomain45441722026-01-012026-03-31RelatedPartyTransactionDomain55441722025-12-31RelatedPartyTransactionDomain55441722026-03-31RelatedPartyTransactionDomain55441722026-01-012026-03-31RelatedPartyTransactionDomain65441722025-12-31RelatedPartyTransactionDomain65441722026-03-31RelatedPartyTransactionDomain65441722026-01-012026-03-31RelatedPartyTransactionDomain75441722025-12-31RelatedPartyTransactionDomain75441722026-03-31RelatedPartyTransactionDomain75441722026-01-012026-03-31RelatedPartyTransactionDomain85441722025-12-31RelatedPartyTransactionDomain85441722026-03-31RelatedPartyTransactionDomain85441722026-01-012026-03-31RelatedPartyTransactionDomain95441722025-12-31RelatedPartyTransactionDomain95441722026-03-31RelatedPartyTransactionDomain95441722026-01-012026-03-31RelatedPartyTransactionDomain105441722025-12-31RelatedPartyTransactionDomain105441722026-03-31RelatedPartyTransactionDomain105441722026-01-012026-03-31RelatedPartyTransactionDomain115441722025-12-31RelatedPartyTransactionDomain115441722026-03-31RelatedPartyTransactionDomain115441722026-01-012026-03-31RelatedPartyTransactionDomain125441722025-12-31RelatedPartyTransactionDomain125441722026-03-31RelatedPartyTransactionDomain125441722026-01-012026-03-31RelatedPartyTransactionDomain135441722025-12-31RelatedPartyTransactionDomain135441722026-03-31RelatedPartyTransactionDomain135441722026-01-012026-03-31RelatedPartyTransactionDomain145441722025-12-31RelatedPartyTransactionDomain145441722026-03-31RelatedPartyTransactionDomain145441722026-01-012026-03-31RelatedPartyTransactionDomain155441722025-12-31RelatedPartyTransactionDomain155441722026-03-31RelatedPartyTransactionDomain155441722026-01-012026-03-31RelatedPartyTransactionDomain165441722025-12-31RelatedPartyTransactionDomain165441722026-03-31RelatedPartyTransactionDomain165441722026-01-012026-03-31RelatedPartyTransactionDomain175441722025-12-31RelatedPartyTransactionDomain175441722026-03-31RelatedPartyTransactionDomain175441722026-01-012026-03-31RelatedPartyTransactionDomain185441722025-12-31RelatedPartyTransactionDomain185441722026-03-31RelatedPartyTransactionDomain185441722026-01-012026-03-31RelatedPartyTransactionDomain195441722025-12-31RelatedPartyTransactionDomain195441722026-03-31RelatedPartyTransactionDomain195441722026-01-012026-03-31RelatedPartyTransactionDomain205441722025-12-31RelatedPartyTransactionDomain205441722026-03-31RelatedPartyTransactionDomain205441722026-01-012026-03-31RelatedPartyTransactionDomain215441722025-12-31RelatedPartyTransactionDomain215441722026-03-31RelatedPartyTransactionDomain215441722026-01-012026-03-31RelatedPartyTransactionDomain225441722025-12-31RelatedPartyTransactionDomain225441722026-03-31RelatedPartyTransactionDomain225441722026-01-012026-03-31RelatedPartyTransactionDomain235441722025-12-31RelatedPartyTransactionDomain235441722026-03-31RelatedPartyTransactionDomain235441722026-01-012026-03-31RelatedPartyTransactionDomain245441722025-12-31RelatedPartyTransactionDomain245441722026-03-31RelatedPartyTransactionDomain245441722026-01-012026-03-31RelatedPartyTransactionDomain255441722025-12-31RelatedPartyTransactionDomain255441722026-03-31RelatedPartyTransactionDomain255441722026-01-012026-03-31RelatedPartyTransactionDomain265441722025-12-31RelatedPartyTransactionDomain265441722026-03-31RelatedPartyTransactionDomain265441722026-01-012026-03-31RelatedPartyTransactionDomain275441722025-12-31RelatedPartyTransactionDomain275441722026-03-31RelatedPartyTransactionDomain275441722026-01-012026-03-31RelatedPartyTransactionDomain285441722025-12-31RelatedPartyTransactionDomain285441722026-03-31RelatedPartyTransactionDomain285441722026-01-012026-03-31RelatedPartyTransactionDomain295441722025-12-31RelatedPartyTransactionDomain295441722026-03-31RelatedPartyTransactionDomain295441722026-01-012026-03-31RelatedPartyTransactionDomain305441722025-12-31RelatedPartyTransactionDomain305441722026-03-31RelatedPartyTransactionDomain305441722026-01-012026-03-31RelatedPartyTransactionDomain315441722025-12-31RelatedPartyTransactionDomain315441722026-03-31RelatedPartyTransactionDomain315441722026-01-012026-03-31RelatedPartyTransactionDomain325441722025-12-31RelatedPartyTransactionDomain325441722026-03-31RelatedPartyTransactionDomain325441722026-01-012026-03-31RelatedPartyTransactionDomain335441722025-12-31RelatedPartyTransactionDomain335441722026-03-31RelatedPartyTransactionDomain335441722026-01-012026-03-31RelatedPartyTransactionDomain345441722025-12-31RelatedPartyTransactionDomain345441722026-03-31RelatedPartyTransactionDomain345441722026-01-012026-03-31RelatedPartyTransactionDomain355441722025-12-31RelatedPartyTransactionDomain355441722026-03-31RelatedPartyTransactionDomain355441722026-01-012026-03-31RelatedPartyTransactionDomain365441722025-12-31RelatedPartyTransactionDomain365441722026-03-31RelatedPartyTransactionDomain365441722026-01-012026-03-31RelatedPartyTransactionDomain375441722025-12-31RelatedPartyTransactionDomain375441722026-03-31RelatedPartyTransactionDomain375441722026-01-012026-03-31RelatedPartyTransactionDomain385441722025-12-31RelatedPartyTransactionDomain385441722026-03-31RelatedPartyTransactionDomain385441722026-01-012026-03-31RelatedPartyTransactionDomain395441722025-12-31RelatedPartyTransactionDomain395441722026-03-31RelatedPartyTransactionDomain395441722026-01-012026-03-31RelatedPartyTransactionDomain405441722025-12-31RelatedPartyTransactionDomain405441722026-03-31RelatedPartyTransactionDomain405441722026-01-012026-03-31RelatedPartyTransactionDomain415441722025-12-31RelatedPartyTransactionDomain415441722026-03-31RelatedPartyTransactionDomain415441722026-01-012026-03-31RelatedPartyTransactionDomain425441722025-12-31RelatedPartyTransactionDomain425441722026-03-31RelatedPartyTransactionDomain425441722026-01-012026-03-31RelatedPartyTransactionDomain435441722025-12-31RelatedPartyTransactionDomain435441722026-03-31RelatedPartyTransactionDomain435441722026-01-012026-03-31RelatedPartyTransactionDomain445441722025-12-31RelatedPartyTransactionDomain445441722026-03-31RelatedPartyTransactionDomain445441722026-01-012026-03-31RelatedPartyTransactionDomain455441722025-12-31RelatedPartyTransactionDomain455441722026-03-31RelatedPartyTransactionDomain455441722026-01-012026-03-31RelatedPartyTransactionDomain465441722025-12-31RelatedPartyTransactionDomain465441722026-03-31RelatedPartyTransactionDomain465441722026-01-012026-03-31RelatedPartyTransactionDomain475441722025-12-31RelatedPartyTransactionDomain475441722026-03-31RelatedPartyTransactionDomain475441722026-01-012026-03-31RelatedPartyTransactionDomain485441722025-12-31RelatedPartyTransactionDomain485441722026-03-31RelatedPartyTransactionDomain485441722026-01-012026-03-31RelatedPartyTransactionDomain495441722025-12-31RelatedPartyTransactionDomain495441722026-03-31RelatedPartyTransactionDomain495441722026-01-012026-03-31RelatedPartyTransactionDomain505441722025-12-31RelatedPartyTransactionDomain505441722026-03-31RelatedPartyTransactionDomain505441722026-01-012026-03-31RelatedPartyTransactionDomain515441722025-12-31RelatedPartyTransactionDomain515441722026-03-31RelatedPartyTransactionDomain515441722026-01-012026-03-31RelatedPartyTransactionDomain525441722025-12-31RelatedPartyTransactionDomain525441722026-03-31RelatedPartyTransactionDomain525441722026-01-012026-03-31RelatedPartyTransactionDomain535441722025-12-31RelatedPartyTransactionDomain535441722026-03-31RelatedPartyTransactionDomain535441722026-01-012026-03-31RelatedPartyTransactionDomain545441722025-12-31RelatedPartyTransactionDomain545441722026-03-31RelatedPartyTransactionDomain545441722026-01-012026-03-31RelatedPartyTransactionDomain555441722025-12-31RelatedPartyTransactionDomain555441722026-03-31RelatedPartyTransactionDomain555441722026-01-012026-03-31RelatedPartyTransactionDomain565441722025-12-31RelatedPartyTransactionDomain565441722026-03-31RelatedPartyTransactionDomain565441722026-01-012026-03-31RelatedPartyTransactionDomain575441722025-12-31RelatedPartyTransactionDomain575441722026-03-31RelatedPartyTransactionDomain575441722026-01-012026-03-31RelatedPartyTransactionDomain585441722025-12-31RelatedPartyTransactionDomain585441722026-03-31RelatedPartyTransactionDomain585441722026-01-012026-03-31RelatedPartyTransactionDomain595441722025-12-31RelatedPartyTransactionDomain595441722026-03-31RelatedPartyTransactionDomain595441722026-01-012026-03-31RelatedPartyTransactionDomain605441722025-12-31RelatedPartyTransactionDomain605441722026-03-31RelatedPartyTransactionDomain605441722026-01-012026-03-31RelatedPartyTransactionDomain615441722025-12-31RelatedPartyTransactionDomain615441722026-03-31RelatedPartyTransactionDomain615441722026-01-012026-03-31RelatedPartyTransactionDomain625441722025-12-31RelatedPartyTransactionDomain625441722026-03-31RelatedPartyTransactionDomain625441722026-01-012026-03-31RelatedPartyTransactionDomain635441722025-12-31RelatedPartyTransactionDomain635441722026-03-31RelatedPartyTransactionDomain635441722026-01-012026-03-31RelatedPartyTransactionDomain645441722025-12-31RelatedPartyTransactionDomain645441722026-03-31RelatedPartyTransactionDomain645441722026-01-012026-03-31RelatedPartyTransactionDomain655441722025-12-31RelatedPartyTransactionDomain655441722026-03-31RelatedPartyTransactionDomain655441722026-01-012026-03-31RelatedPartyTransactionDomain665441722025-12-31RelatedPartyTransactionDomain665441722026-03-31RelatedPartyTransactionDomain665441722026-01-012026-03-31RelatedPartyTransactionDomain675441722025-12-31RelatedPartyTransactionDomain675441722026-03-31RelatedPartyTransactionDomain675441722026-01-012026-03-31RelatedPartyTransactionDomain685441722025-12-31RelatedPartyTransactionDomain685441722026-03-31RelatedPartyTransactionDomain685441722026-01-012026-03-31RelatedPartyTransactionDomain695441722025-12-31RelatedPartyTransactionDomain695441722026-03-31RelatedPartyTransactionDomain695441722026-01-012026-03-31RelatedPartyTransactionDomain705441722025-12-31RelatedPartyTransactionDomain705441722026-03-31RelatedPartyTransactionDomain705441722026-01-012026-03-31RelatedPartyTransactionDomain715441722025-12-31RelatedPartyTransactionDomain715441722026-03-31RelatedPartyTransactionDomain715441722026-01-012026-03-31RelatedPartyTransactionDomain725441722025-12-31RelatedPartyTransactionDomain725441722026-03-31RelatedPartyTransactionDomain725441722026-01-012026-03-31RelatedPartyTransactionDomain735441722025-12-31RelatedPartyTransactionDomain735441722026-03-31RelatedPartyTransactionDomain735441722026-01-012026-03-31RelatedPartyTransactionDomain745441722025-12-31RelatedPartyTransactionDomain745441722026-03-31RelatedPartyTransactionDomain745441722026-01-012026-03-31RelatedPartyTransactionDomain755441722025-12-31RelatedPartyTransactionDomain755441722026-03-31RelatedPartyTransactionDomain755441722026-01-012026-03-31RelatedPartyTransactionDomain765441722025-12-31RelatedPartyTransactionDomain765441722026-03-31RelatedPartyTransactionDomain765441722026-01-012026-03-31RelatedPartyTransactionDomain775441722025-12-31RelatedPartyTransactionDomain775441722026-03-31RelatedPartyTransactionDomain775441722026-01-012026-03-31RelatedPartyTransactionDomain785441722025-12-31RelatedPartyTransactionDomain785441722026-03-31RelatedPartyTransactionDomain785441722026-01-012026-03-31RelatedPartyTransactionDomain795441722025-12-31RelatedPartyTransactionDomain795441722026-03-31RelatedPartyTransactionDomain795441722026-01-012026-03-31RelatedPartyTransactionDomain805441722025-12-31RelatedPartyTransactionDomain805441722026-03-31RelatedPartyTransactionDomain805441722026-01-012026-03-31RelatedPartyTransactionDomain815441722025-12-31RelatedPartyTransactionDomain815441722026-03-31RelatedPartyTransactionDomain815441722026-01-012026-03-31RelatedPartyTransactionDomain825441722025-12-31RelatedPartyTransactionDomain825441722026-03-31RelatedPartyTransactionDomain825441722026-01-012026-03-31RelatedPartyTransactionDomain835441722025-12-31RelatedPartyTransactionDomain835441722026-03-31RelatedPartyTransactionDomain835441722026-01-012026-03-31RelatedPartyTransactionDomain845441722025-12-31RelatedPartyTransactionDomain845441722026-03-31RelatedPartyTransactionDomain845441722026-01-012026-03-31RelatedPartyTransactionDomain855441722025-12-31RelatedPartyTransactionDomain855441722026-03-31RelatedPartyTransactionDomain855441722026-01-012026-03-31RelatedPartyTransactionDomain865441722025-12-31RelatedPartyTransactionDomain865441722026-03-31RelatedPartyTransactionDomain865441722026-01-012026-03-31RelatedPartyTransactionDomain875441722025-12-31RelatedPartyTransactionDomain875441722026-03-31RelatedPartyTransactionDomain875441722026-01-012026-03-31RelatedPartyTransactionDomain885441722025-12-31RelatedPartyTransactionDomain885441722026-03-31RelatedPartyTransactionDomain885441722026-01-012026-03-31RelatedPartyTransactionDomain895441722025-12-31RelatedPartyTransactionDomain895441722026-03-31RelatedPartyTransactionDomain895441722026-01-012026-03-31RelatedPartyTransactionDomain905441722025-12-31RelatedPartyTransactionDomain905441722026-03-31RelatedPartyTransactionDomain905441722026-01-012026-03-31RelatedPartyTransactionDomain915441722025-12-31RelatedPartyTransactionDomain915441722026-03-31RelatedPartyTransactionDomain915441722026-01-012026-03-31RelatedPartyTransactionDomain925441722025-12-31RelatedPartyTransactionDomain925441722026-03-31RelatedPartyTransactionDomain925441722026-01-012026-03-31RelatedPartyTransactionDomain935441722025-12-31RelatedPartyTransactionDomain935441722026-03-31RelatedPartyTransactionDomain935441722026-01-012026-03-31RelatedPartyTransactionDomain945441722025-12-31RelatedPartyTransactionDomain945441722026-03-31RelatedPartyTransactionDomain945441722026-01-012026-03-31RelatedPartyTransactionDomain955441722025-12-31RelatedPartyTransactionDomain955441722026-03-31RelatedPartyTransactionDomain955441722026-01-012026-03-31RelatedPartyTransactionDomain965441722025-12-31RelatedPartyTransactionDomain965441722026-03-31RelatedPartyTransactionDomain965441722026-01-012026-03-31RelatedPartyTransactionDomain975441722025-12-31RelatedPartyTransactionDomain975441722026-03-31RelatedPartyTransactionDomain975441722026-01-012026-03-31RelatedPartyTransactionDomain985441722025-12-31RelatedPartyTransactionDomain985441722026-03-31RelatedPartyTransactionDomain985441722026-01-012026-03-31RelatedPartyTransactionDomain995441722025-12-31RelatedPartyTransactionDomain995441722026-03-31RelatedPartyTransactionDomain995441722026-01-012026-03-31RelatedPartyTransactionDomain1005441722025-12-31RelatedPartyTransactionDomain1005441722026-03-31RelatedPartyTransactionDomain1005441722026-01-012026-03-31RelatedPartyTransactionDomain1015441722025-12-31RelatedPartyTransactionDomain1015441722026-03-31RelatedPartyTransactionDomain1015441722026-01-012026-03-31RelatedPartyTransactionDomain1025441722025-12-31RelatedPartyTransactionDomain1025441722026-03-31RelatedPartyTransactionDomain1025441722026-01-012026-03-31RelatedPartyTransactionDomain1035441722025-12-31RelatedPartyTransactionDomain1035441722026-03-31RelatedPartyTransactionDomain1035441722026-01-012026-03-31RelatedPartyTransactionDomain1045441722025-12-31RelatedPartyTransactionDomain1045441722026-03-31RelatedPartyTransactionDomain1045441722026-01-012026-03-31RelatedPartyTransactionDomain1055441722025-12-31RelatedPartyTransactionDomain1055441722026-03-31RelatedPartyTransactionDomain1055441722026-01-012026-03-31RelatedPartyTransactionDomain1065441722025-12-31RelatedPartyTransactionDomain1065441722026-03-31RelatedPartyTransactionDomain1065441722026-01-012026-03-31RelatedPartyTransactionDomain1075441722025-12-31RelatedPartyTransactionDomain1075441722026-03-31RelatedPartyTransactionDomain1075441722026-01-012026-03-31RelatedPartyTransactionDomain1085441722025-12-31RelatedPartyTransactionDomain1085441722026-03-31RelatedPartyTransactionDomain1085441722026-01-012026-03-31AuditorDomain1iso4217:INRxbrli:pureiso4217:INRxbrli:shares544172INDGNNOTLISTEDINE065X01017Indegene LimitedMain BoardEquity2025-04-012026-03-312026-04-292026-04-21INRMillionsQuarterlyFourth quarterSingle segmentWhere financial results contain both consolidated financial results and standalone financial results of the parent, segment information is required to be presented only in the consolidated financial results. Accordingly, segment information has been presented in the consolidated financial results.2026-04-2917:30:002026-04-2919:10:00trueCash Flow IndirectDeclaration of unmodified opiniontruetrueNANAfalsetrue2026-04-29https://ir.indegene.com/en/investor-relations/corporate-governance/falsefalseNo external loans and debt securities held by Company2026-01-012026-03-31UnauditedStandalone368200000061000000374300000000021340000003100000010900000051700000027910000009520000000952000000260000000-2900000023100000007210000000000721000000-59000000662000000481000000232.980032.98Earnings per share is not annualised for quarter ended <BR> <BR> 1 The above Standalone Financial Results of the Indegene Limited the Company have been prepared in accordance with Indian Accounting Standards Ind AS 34 Interim Financial Reporting recognition and measurement principles of Indian Accounting Standards Ind AS prescribed under Section 133 of the Companies Act 2013 as amended read with the relevant rules issued there under and in terms of Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements Regulations 2015 the Regulations Due to rounding off the numbers presented throughout may not add up precisely to the totals Caret symbol in the financial information denote amounts less than INR 50 lakh <BR> <BR> 2 The above Standalone Financial Results have been reviewed by the Audit Committee held on 28 April 2026 and approved by the Board of Directors at its meeting held on 29 April 2026 The figures for the quarter ended 31 March 2026 and 31 March 2025 are the balancing figures between audited figures in respect of full financial year and published unaudited year to date figures upto the end of the third quarter of the current financial year which were subject to limited review <BR> <BR> 3 The Standalone Financial Results for the quarter and year ended 31 March 2026 are available on the National Stock Exchange of India Limited URL www nseindia com the BSE Limited website URL www bseindia com and on the Company s website URL www indegene com investor relations <BR> <BR> 4 During the year ended 31 March 2025 the Company had completed Initial Public Offer IPO of 40766550 equity shares of face value of INR 2 each at an issue price of INR 452 per share Issue price of INR 422 including a share premium of INR 420 per share for employee quota towards fresh issue comprising fresh issue of 16833818 shares aggregating to INR 7600 and offer for sale of 23932732 shares by selling shareholders aggregating to INR 10818 The equity shares of the Company are listed in National Stock Exchange of India Limited NSE and BSE Limited BSE on 13 May 2024 The Company has received an amount of INR 7246 net of Company s share of IPO expenses of INR 354 retained in the Public Offer Account to the extent unpaid from the proceeds of the fresh issue Out of the Company s shares of IPO expenses INR 319 has been adjusted to securities premium <BR> The utilization of IPO proceeds of INR 7246 <BR> <BR> Repayment or prepayment of indebtedness of one of the material subsidiary ILSL Holdings Inc The amount to be utilised as per the offer document is 3950 The amount utilized up to 31 March 2026 is 3950 The amount unutilized as of 31 March 2026 is nil <BR> <BR> Funding the capital expenditure requirements of the Company and one of the material subsidiary Indegene Inc The amount to be utilised as per the offer document is 644 The amount utilized up to 31 March 2026 is 577 The amount unutilized as of 31 March 2026 is 67 <BR> <BR> Technology cybersecurity and cloud infrastructure related cost The amount to be utilised as per the offer document is 350 The amount utilized up to 31 March 2026 is 253 The amount unutilized as of 31 March 2026 is 97 <BR> <BR> General corporate purposes and inorganic growth The amount to be utilised as per the offer document is 2302 The amount utilized up to 31 March 2026 is 2294 The amount unutilized as of 31 March 2026 is 8 <BR> <BR> The total amount to be utilised as per the offer document is 7246 The total amount utilized up to 31 March 2026 is 7074 The total amount unutilized as of 31 March 2026 is 172 <BR> <BR> 1 Pursuant to the Special Resolution passed at the Shareholders Meeting held on 12 August 2025 the Company has revised the objects as per offer document As per the revised objects an amount of INR 37 is adjusted from funding capital expenditure requirements towards repayment of indebtedness of ILSL Holdings Inc for the difference arising due to exchange rate fluctuation as on the date of offer document and as on the date of repayment Further an amount of INR 350 is reclassified from funding capital expenditure requirement towards utilization for services including cloud infrastructure and security services productivity tools cybersecurity and support services availed by the Company and Indegene Inc Further the Board of Directors of the Company has approved the transfer of unutilized IPO expense towards funding capital expenditure requirement by way of Board Resolution passed on 29 January 2026 The unutilized amount of INR 2 has been transferred to the net IPO proceeds thereby increasing it from INR 7244 to INR 7246 and earmarked for funding capital expenditure requirements at the Company s office premises <BR> <BR> 2 During the year ended 31 March 2025 the Company has repaid loan of USD 47 Million INR 3950 outstanding in the books of ILSL Holdings Inc material subsidiary in line with Object 1 of the offer document The amount of INR 37 utilised over and above the maximum amount specified as per the original amount as per offer document of INR 3913 was due to exchange rate fluctuation as on the date of offer document and as on the date of payment The Special Resolution passed on 12 August 2025 revises the object amount to adjust this difference <BR> <BR> Out of the net proceeds which were unutilised as at 31 March 2026 INR 151 31 March 2025 INR 980 are temporarily invested in fixed deposits INR 19 31 March 2025 INR 41 is held in the Company s monitoring account while the balance amount of INR 2 31 March 2025 Nil is held in the public offer account2025-04-012026-03-31AuditedStandalone1220600000078300000012989000000000795200000087000000363000000177300000010175000000281400000002814000000707000000-120000006950000000211900000000002119000000-2800000020910000004810000002203240000008.838.78008.838.78Other expenses517000000Other expenses17730000001126000000118000000000000616600000003550000000693000000104090000002380000001790000001207000000007016000000288400000048500000081100000044300000029100000011930000000081900000012749000000002481900000048100000020324000000208050000002080500000000006190000006190000006570000000012760000000260000003000000003260000001296000000162200000027200000053400000031000000002738000000004014000000248190000006 On 21 November 2025 the Government of India notified provisions of the Code on Wages 2019 the Industrial Relations Code 2020 the Code on Social Security 2020 and the Occupational Safety Health and Working Conditions Code 2020 Labour Codes which consolidate twenty nine existing labour laws into a unified framework governing employee benefits during employment and post employment The Labour Codes amongst other things introduces changes including a uniform definition of wages and enhanced benefits relating to leave The Company has considered restructured compensation of its employees with effect from 01 April 2026 and assessed the impact of the changes consistent with the Labour Codes draft rules FAQs and legal opinion The Company based on the evaluation of the labour code has concluded that these changes do not have any material impact on the Company s Financial Statements In case of any further clarification from the Government on other aspects of the New Labour Codes the Company will evaluate and account for differential impact if any in subsequent periods on the Financial Statements <BR> <BR> 7 During the year ended 31 March 2026 613772 options have been granted under Employee Restricted Stock Unit plan 2020 RSU 2020 318251 options have been granted under Employee Stock Option Plan 2020 ESOP 2020 and 56462 options have been granted under Company Share Option Plan 2022 CSOP 2022 to the eligible employee of the Company 670418 options under RSU 2020 plan 215192 options under ESOP 2020 plan and 7782 options under ESOP 2020 plan have been exercised during the year <BR> <BR> 8 The Company publishes this Standalone Financial Results along with the Consolidated Financial Results In accordance with Ind AS 108 Operating Segments the Company has disclosed the segment information in the Consolidated Financial Results <BR> <BR> 9 Contingencies <BR> During the year the Company received a draft transfer pricing order dated 18 March 2026 pertaining to Assessment Year 2023 24 issued by the Transfer Pricing Officer under the provisions of the Income tax Act 1961 proposing adjustments to the Companys returned income in respect of international transactions with associated enterprises The proposed transfer pricing adjustment in the draft order aggregates to INR 1 114 the amount of tax demand will be as per the final order which is not received as on date The Company has exercised its option to seek resolution of the proposed adjustment through the Mutual Agreement Procedure MAP in accordance with the applicable tax treaty provisions between India and the relevant treaty jurisdiction s The MAP application has been filed within the prescribed timelines <BR> Based on management s assessment supported by external tax advice and considering the merits of the case including the Company s transfer pricing documentation economic analyses and relevant judicial precedents management believes that the matter is effectively contestable and that it is not probable that an outflow of resources will be required to settle the obligation Accordingly no provision has been recognised in the financial statements as at the reporting date and the proposed exposure has been disclosed as a contingent liability pending resolution under the MAP process <BR> <BR> 10 The Board of Directors in its meeting on 29 April 2026 have proposed a final dividend of INR 2 point 25 per equity shares for the financial year ended 31 March 2026 The proposal is subject to the approval of shareholders at the ensuing Annual General Meeting and if approved would result in a cash outflow of approximately INR 542 <BR> <BR> <BR> <BR> Notes to Assets and Liabilites <BR> a Property plant and equipment includes Right of use assets of INR 673 <BR> b Trade receivables current consists Billed Revenue INR 2834 and Unbilled revenue of INR 50 <BR> Other financial assets693000000Non-current tax assets (net)172000000Other non-current assets7000000Other financial assets291000000Other current assets819000000Lease liabilities480000000Other financial liabilities139000000Lease liabilities218000000Other financial liabilities1078000000Other current liabilities272000000I Cash flows from Operating Activities <BR> 1 Other adjustments for non-cash items includes <BR> a Reversals of provision for diminution in value of loans and interest INR negative 3 <BR> b Expected credit loss provision on trade receivables and advances INR negative 7 <BR> c Gain on termination of lease INR negative 9 <BR> <BR> 2 Cash flows from Investing Activities <BR> A Other Inflow Outflows of cash includes <BR> a Purchase of investments accounted using FVTPL INR negative 4440 <BR> b Proceeds from redemption of investments INR 2757 <BR> c Investments in fixed deposits INR negative 3669 <BR> d Redemption or maturity of fixed deposit INR 3617 <BR> <BR> 3 Cash flows from Financing Activities <BR> Proceeds from issuing shares is net of share issue expenses79000000013960000000-174000000000000-78000000036300000001350000000007900000004440000008400000000-3000000000-19000000011210000003935000000000479000000034560000000001453000000000004410000000000000000000000004970000000-1324000000-272100000000530000000000000199000000480000000000-62600000010900000024000000133000000352000000485000000Remeasurement of defined benefit obligation-1000000-1000000Remeasurement of defined benefit obligation4100000041000000-100000010000000Fair value gain/(loss) arising on hedging instruments during the year-79000000-79000000Fair value gain/(loss) arising on hedging instruments during the year-79000000-79000000-20000000-20000000-59000000-28000000Indegene Limited******Cult Health LLC******Step SubsidiarySale of goods or services30100000Approved21000000130000005000000Indegene Limited******DT Associates Research and Consulting Services Limited******Step SubsidiarySale of goods or services77400000Approved310000002100000028000000Indegene Limited******Indegene FarEast Pte. Ltd.******Step SubsidiarySale of goods or services6880000Approved200000002000000Indegene Limited******Indegene Healthcare Canada, Inc.******Step SubsidiarySale of goods or services8600000Approved000Indegene Limited******Indegene Ireland Limited******SubsidiarySale of goods or services8600000Approved200000002000000Indegene Limited******Indegene Japan LLC******Step SubsidiarySale of goods or services10750000Approved400000010000001000000Indegene Limited******Indegene Lifesystems Consulting (Shanghai) Co. Ltd.******Step SubsidiarySale of goods or services45150000Approved140000001300000015000000Indegene Limited******Indegene, Inc.******Step SubsidiarySale of goods or services10750000000Approved571900000043380000002488000000Indegene Limited******Trilogy Writing & Consulting GmbH******Step SubsidiarySale of goods or services17200000Approved600000001000000Indegene Limited******Trilogy Writing & Consulting Inc******Step SubsidiarySale of goods or services8600000Approved200000001000000Indegene Limited******Trilogy Writing & Consulting Limited******Step SubsidiarySale of goods or services8600000Approved000Indegene Limited******Trilogy Writing & Consulting ULC******Step SubsidiarySale of goods or services8600000Approved000Indegene, Inc.******Cult Health LLC******Fellow SubisidarySale of goods or servicesNot Applicable900000020000002000000Indegene, Inc.******DT Associates Research and Consulting Services Inc******Fellow SubisidarySale of goods or servicesNot Applicable320000003200000048000000Indegene, Inc.******DT Associates Research and Consulting Services Limited******Fellow SubisidarySale of goods or servicesNot Applicable6000000310000003000000Indegene, Inc.******Indegene Ireland Limited******Fellow SubisidarySale of goods or servicesNot Applicable100000000Biopharm Communications, LLC******Addressable Health LLC******Fellow SubisidarySale of goods or servicesNot Applicable57000000043000000Biopharm Communications, LLC******Indegene, Inc.******Parent CompanySale of goods or servicesNot Applicable2900000000Cult Health LLC******Indegene, Inc.******Fellow SubisidarySale of goods or servicesNot Applicable26600000010100000087000000DT Associates Research and Consulting Services Inc******DT Associates Research and Consulting Services Limited******Fellow SubisidarySale of goods or servicesNot Applicable3400000075000000114000000DT Associates Research and Consulting Services Inc******Indegene, Inc.******Fellow SubisidarySale of goods or servicesNot Applicable220000007000000-93000000DT Associates Research and Consulting Services Limited******Indegene Healthcare UK Ltd******Fellow SubisidarySale of goods or servicesNot Applicable200000000DT Associates Research and Consulting Services Limited******Indegene, Inc.******Fellow SubisidarySale of goods or servicesNot Applicable27000000021700000060000000Indegene Europe LLC******Indegene, Inc.******Fellow SubisidarySale of goods or servicesNot Applicable650000003900000014000000Indegene FarEast Pte. Ltd.******Indegene Japan LLC******Fellow SubisidarySale of goods or servicesNot Applicable300000020000000Indegene FarEast Pte. Ltd.******Indegene, Inc.******Fellow SubisidarySale of goods or servicesNot Applicable2100000020000003000000Indegene Healthcare Canada, Inc.******Indegene, Inc.******Parent CompanySale of goods or servicesNot Applicable1110000000182000000Indegene Healthcare Canada, Inc.******Trilogy Writing & Consulting GmbH******Fellow SubisidarySale of goods or servicesNot Applicable22000000086000000Indegene Healthcare Canada, Inc.******Trilogy Writing & Consulting Inc******Fellow SubisidarySale of goods or servicesNot Applicable1300000001000000Indegene Healthcare Germany GmbH******Indegene, Inc.******Fellow SubisidarySale of goods or servicesNot Applicable1820000002800000027000000Indegene Healthcare UK Ltd******Indegene Limited******Ultimate Parent CompanySale of goods or servicesNot Applicable4900000009000000Indegene Healthcare UK Ltd******Indegene, Inc.******Fellow SubisidarySale of goods or servicesNot Applicable4050000006300000062000000Indegene Ireland Limited******Indegene, Inc.******Fellow SubisidarySale of goods or servicesNot Applicable53000000600000013000000Indegene Japan******DT Associates Research and Consulting Services Limited******Fellow SubisidarySale of goods or servicesNot Applicable100000000Indegene Japan******Indegene, Inc.******Fellow SubisidarySale of goods or servicesNot Applicable2400000000Indegene Lifesystems Consulting (Shanghai) Co. Ltd.******Indegene, Inc.******Fellow SubisidarySale of goods or servicesNot Applicable6900000000Indegene Spain SL******DT Associates Research and Consulting Services Limited******Fellow SubisidarySale of goods or servicesNot Applicable800000004000000Indegene Spain SL******Indegene Limited******Ultimate Parent CompanySale of goods or servicesNot Applicable100000001000000Indegene Spain SL******Indegene, Inc.******Fellow SubisidarySale of goods or servicesNot Applicable1300000004000000MJL Advertising Limited******Indegene, Inc.******Fellow SubisidarySale of goods or servicesNot Applicable1400000007000000Services Indegene Aptilon, Inc.******Indegene, Inc.******Parent CompanySale of goods or servicesNot Applicable950000001670000000Trilogy Writing & Consulting GmbH******Indegene, Inc.******Fellow SubisidarySale of goods or servicesNot Applicable500000010000003000000Trilogy Writing & Consulting GmbH******Trilogy Writing & Consulting Inc******SubsidiarySale of goods or servicesNot Applicable339000000239000000607000000Trilogy Writing & Consulting Inc******Indegene, Inc.******Fellow SubisidarySale of goods or servicesNot Applicable300000000Trilogy Writing & Consulting Inc******Trilogy Writing & Consulting GmbH******Parent CompanySale of goods or servicesNot Applicable304000000486000000837000000Trilogy Writing & Consulting Limited******Trilogy Writing & Consulting GmbH******Fellow SubisidarySale of goods or servicesNot Applicable74000000-81000000-85000000Trilogy Writing & Consulting Limited******Trilogy Writing & Consulting Inc******Fellow SubisidarySale of goods or servicesNot Applicable9800000092000000198000000Trilogy Writing & Consulting ULC******Trilogy Writing & Consulting GmbH******Fellow SubisidarySale of goods or servicesNot Applicable6000000000Trilogy Writing & Consulting ULC******Trilogy Writing & Consulting Inc******Fellow SubisidarySale of goods or servicesNot Applicable-2000000500000000Warn & Co Limited******Indegene, Inc.******Fellow SubisidarySale of goods or servicesNot Applicable1200000003000000Indegene Limited******Cult Health LLC******Step SubsidiaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable700000002000000Indegene Limited******DT Associates Research and Consulting Services Limited******Step SubsidiaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable-5000000125000000125000000Indegene Limited******Indegene FarEast Pte. Ltd.******Step SubsidiaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable100000000Indegene Limited******Indegene Healthcare Germany GmbH******Step SubsidiaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable100000000Indegene Limited******Indegene Healthcare UK Ltd******Step SubsidiaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable2300000030000003000000Indegene Limited******Indegene, Inc.******Step SubsidiaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable880000001200000032000000Indegene Limited******Trilogy Writing & Consulting GmbH******Step SubsidiaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable200000002000000Indegene Limited******Trilogy Writing & Consulting Limited******Step SubsidiaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable200000002000000Indegene, Inc.******Addressable Health LLC******Fellow SubisidaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable300000003000000Indegene, Inc.******Biopharm Communications, LLC******Fellow SubisidaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable2500000003000000Indegene, Inc.******Cult Health LLC******Fellow SubisidaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable710000001100000013000000Indegene, Inc.******DT Associates Research and Consulting Services Limited******Fellow SubisidaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable020000002000000Indegene, Inc.******Indegene Lifesystems Consulting (Shanghai) Co. Ltd.******Fellow SubisidaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable3000000135000000146000000Indegene, Inc.******Indegene Limited******Ultimate Parent CompanyAny other transactionExpenses paid on behalf of subsidiaryNot Applicable200000002000000Indegene, Inc.******MJL Advertising Limited******Fellow SubisidaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable100000001000000Indegene, Inc.******Trilogy Writing & Consulting Inc******Fellow SubisidaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable35000000021000000Biopharm Communications, LLC******Addressable Health LLC******Fellow SubisidaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable3600000000Cult Health LLC******DT Associates Research and Consulting Services Limited******Fellow SubisidaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable300000000Cult Health LLC******Indegene, Inc.******Fellow SubisidaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable100000010000000-29000000Cult Health LLC******MJL Advertising Limited******Fellow SubisidaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable100000000DT Associates Research and Consulting Services Inc******DT Associates Research and Consulting Services Limited******Fellow SubisidaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable010000001000000DT Associates Research and Consulting Services Inc******Indegene, Inc.******Fellow SubisidaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable010000001000000DT Associates Research and Consulting Services Limited******Indegene, Inc.******Fellow SubisidaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable120000003000000044000000IL SL Holdings Inc. USA******Biopharm Communications, LLC******Step SubsidiaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable1400000000IL SL Holdings Inc. USA******Indegene, Inc.******SubsidiaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable1000000000Indegene Healthcare Canada, Inc.******Indegene, Inc.******Parent CompanyAny other transactionExpenses paid on behalf of subsidiaryNot Applicable400000004000000Indegene Healthcare UK Ltd******DT Associates Research and Consulting Services Limited******SubsidiaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable2300000040000004000000Indegene Ireland Limited******Indegene, Inc.******Fellow SubisidaryAny other transactionExpenses paid on behalf of subsidiaryNot Applicable600000000Services Indegene Aptilon, Inc.******Indegene, Inc.******Parent CompanyAny other transactionExpenses paid on behalf of subsidiaryNot Applicable020000000Trilogy Writing & Consulting GmbH******Indegene Limited******Ultimate Parent CompanyAny other transactionExpenses paid on behalf of subsidiaryNot Applicable100000001000000Indegene, Inc.******Indegene Lifesystems Consulting (Shanghai) Co. Ltd.******Fellow SubisidaryAny other transactionAdvance GivenNot Applicable110000003900000050000000Indegene, Inc.******ILSL Holdings, Inc.******Parent CompanyAny other transactionAdvance GivenNot Applicable13950000001196100000013356000000Indegene, Inc.******DT Associates Research and Consulting Services Limited******Fellow SubisidaryAny other transactionAdvance GivenNot Applicable-20500000030000000095000000Indegene, Inc.******Indegene Healthcare Mexico S DE RL DE CV******Fellow SubisidaryAny other transactionAdvance GivenNot Applicable200000002000000Indegene Healthcare UK Ltd******Indegene, Inc.******Fellow SubisidaryAny other transactionAdvance GivenNot Applicable44000000600000050000000Indegene Ireland Limited******Indegene Spain SL******SubsidiaryAny other transactionAdvance GivenNot Applicable6000000500000011000000Indegene Healthcare UK Ltd******DT Associates Research and Consulting Services Limited******SubsidiaryAny other transactionAdvance GivenNot Applicable37000000037000000Indegene Limited******ILSL Holdings, Inc.******SubsidiaryInterest received387000000Approved1790000008900000093000000Indegene Limited******Indegene Lifesystems Consulting (Shanghai) Co. Ltd.******Step SubsidiaryInterest received45150000Approved100000020000003000000Indegene Limited******ILSL Holdings, Inc.******SubsidiaryLoan387000000Approved21500000037720000003987000000Loan0.09045 yearsUnsecuredRepayment/prepayment of the term loan from bankMovement in on account of change in foreign exchange rate and Repayment of LoanIndegene Limited******Indegene Lifesystems Consulting (Shanghai) Co. Ltd.******Step SubsidiaryLoanNot Applicable070000007000000Loan0.085 and 10 yearsUnsecuredBusiness needsTrilogy Writing & Consulting GmbH******Trilogy Writing & Consulting Limited******Fellow SubisidaryLoanNot Applicable06500000068000000Loan0.012520 yearsUnsecuredBusiness needsIndegene Limited******Indegene Ireland Limited******SubsidiaryAny other transactionInvestment in subisidaryNot Applicable145300000026000000004054000000Indegene Limited******Dr. Ashish Gupta******Non- executive Independent DirectorAny other transactionCommission10000000Approved by Board600000050000000Indegene Limited******Mr. Jairaj Manohar Purandare******Non- executive Independent DirectorAny other transactionCommission5000000Approved by Board300000020000000Indegene Limited******Mr. Pravin Udhyavara Bhadya Rao******Non- executive Independent DirectorAny other transactionCommission5000000Approved by Board300000020000000Indegene Limited******Mr. Krishnamurthy Venugopala Tenneti******Non- executive Independent DirectorAny other transactionCommission5000000Approved by Board300000020000000Indegene Limited******Dr. Georgia Nikolakopoulou Papathomas******Non- executive Independent DirectorAny other transactionCommission10000000Approved by Board600000050000000Indegene Limited******Jill DeSimone******Non- executive Independent DirectorAny other transactionCommission10000000Approved by Board300000000Indegene Limited******Neeraj Bharadwaj******Non- executive Independent DirectorAny other transactionCommission10000000Approved by Board300000000Indegene Limited******Manish Gupta******Chief Executive Officer and Executive DirectorRemuneration81250000Approved by Nomination and Remuneration Committee1500000000Indegene Limited******Dr. Sanjay S Parikh******Executive DirectorRemuneration50000000Approved by Nomination and Remuneration Committee1000000000Indegene, Inc.******Dr. Rajesh B Nair******Non- executive DirectorRemuneration25560000Approved by Nomination and Remuneration Committee1400000000Indegene Limited******Ms. Srishti Kaushik******Company SecretaryRemuneration7810000Approved by Nomination and Remuneration Committee300000000Indegene Limited******Suhas Prabhu******Chief Financial OfficerRemuneration50000000Approved by Nomination and Remuneration Committee1600000000ILSL Holdings, Inc.******Indegene Healthcare UK Ltd******Fellow SubisidaryAny other transactionSale of investmentNot Applicable24800000000Trilogy Writing and Consulting GMBH******Indegene, Inc.******Fellow SubisidaryAny other transactionSale of investmentNot Applicable3600000000Trilogy Writing and Consulting GMBH******Indegene Healthcare UK Ltd******Fellow SubisidaryAny other transactionSale of investmentNot Applicable870000000012535000000AuditedtrueDeloitte Haskins & Sellstrue2028-04-30